Related Experiment Videos
Kappa-opioid receptor binding varies inversely with tumor grade in human gliomas
E C Pan1, L M Bohn, M M Belcheva
1E. A. Doisy Department of Biochemistry and Molecular Biology, St. Louis University Health Sciences Center, Missouri 63110-0250, USA.
Background:
Opioid agonists can inhibit cell proliferation in various neural tumor cell lines, including rat gliomas. Because opioid antimitogenic effects are mediated by opioid receptors, it was of interest to the authors to determine opioid receptor levels in human brain tumors.
Methods:
Specimens obtained at craniotomy from 30 patients with glioma and nonneoplastic brain disorders were evaluated for their kappa-opioid receptor binding. Kd and Bmax values were estimated from homologous competition binding curves with the kappa1-selective radioligand [3H]U69,593.
Results:
Receptor binding density was greatest in nonneoplastic brain tissue, less in Grade 2 and 3 astrocytoma, and least in glioblastoma multiforme.
Conclusions:
These results suggest that opioid receptor-based stratification of grade may have clinical utility in distinguishing glioblastoma multiforme from lower grade astrocytomas, and thereby may facilitate diagnosis and treatment.
Insights
Human brain tumors show varying kappa-opioid receptor levels. Glioblastoma multiforme has the least binding, suggesting potential for diagnosis and treatment stratification.
Area of Science:
- Neuro-oncology
- Molecular Pharmacology
- Neuroscience
Background:
- Opioid agonists inhibit neural tumor cell proliferation.
- Opioid antimitogenic effects are mediated by opioid receptors.
- Investigating opioid receptor levels in human brain tumors is of interest.
Purpose of the Study:
- To determine kappa-opioid receptor levels in human brain tumors.
- To assess the correlation between receptor levels and tumor grade.
- To explore the clinical utility of opioid receptor stratification.
Main Methods:
- Evaluated kappa-opioid receptor binding in 30 human brain tumor specimens obtained during craniotomy.
- Utilized homologous competition binding curves with the kappa1-selective radioligand [3H]U69,593.
- Estimated dissociation constant (Kd) and maximum binding capacity (Bmax) values.
Main Results:
- Receptor binding density was highest in nonneoplastic brain tissue.
- Lower receptor binding density was observed in Grade 2 and 3 astrocytomas.
- Glioblastoma multiforme exhibited the lowest kappa-opioid receptor binding density.
Conclusions:
- Opioid receptor levels differ significantly across human brain tumor grades.
- Stratification based on opioid receptor binding may aid in distinguishing glioblastoma multiforme from lower-grade astrocytomas.
- These findings suggest potential clinical utility for opioid receptor analysis in glioma diagnosis and treatment planning.